Article Type
Changed
Tue, 10/30/2018 - 12:14
Display Headline
Managing the hematologic side effects of antiviral therapy for chronic hepatitis C
Anemia, neutropenia, and thrombocytopenia
Article PDF
Author and Disclosure Information

Janus P. Ong, MD
Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, Va

Zobair M. Younossi, MD, MPH
Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, Va

Correspondence: Zobair Younossi, MD, MPH, Center for Liver Diseases, Inova Fairfax Hospital, 3300 Gallows Road, Falls Church, VA 22042; e-mail: zobair.younossi@inova.com

Dr. Ong reported that he has no commercial affiliations or interests that pose a potential conflict of interest with this article.

Dr. Younossi reported that he has received grant or research support from, serves as a consultant to, and is on the speakers’ bureaus of the Roche, Schering-Plough, Amgen, Ortho Biotech, and Axcan corporations.

Publications
Page Number
S17-S21
Author and Disclosure Information

Janus P. Ong, MD
Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, Va

Zobair M. Younossi, MD, MPH
Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, Va

Correspondence: Zobair Younossi, MD, MPH, Center for Liver Diseases, Inova Fairfax Hospital, 3300 Gallows Road, Falls Church, VA 22042; e-mail: zobair.younossi@inova.com

Dr. Ong reported that he has no commercial affiliations or interests that pose a potential conflict of interest with this article.

Dr. Younossi reported that he has received grant or research support from, serves as a consultant to, and is on the speakers’ bureaus of the Roche, Schering-Plough, Amgen, Ortho Biotech, and Axcan corporations.

Author and Disclosure Information

Janus P. Ong, MD
Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, Va

Zobair M. Younossi, MD, MPH
Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, Va

Correspondence: Zobair Younossi, MD, MPH, Center for Liver Diseases, Inova Fairfax Hospital, 3300 Gallows Road, Falls Church, VA 22042; e-mail: zobair.younossi@inova.com

Dr. Ong reported that he has no commercial affiliations or interests that pose a potential conflict of interest with this article.

Dr. Younossi reported that he has received grant or research support from, serves as a consultant to, and is on the speakers’ bureaus of the Roche, Schering-Plough, Amgen, Ortho Biotech, and Axcan corporations.

Article PDF
Article PDF
Anemia, neutropenia, and thrombocytopenia
Anemia, neutropenia, and thrombocytopenia
Page Number
S17-S21
Page Number
S17-S21
Publications
Publications
Article Type
Display Headline
Managing the hematologic side effects of antiviral therapy for chronic hepatitis C
Display Headline
Managing the hematologic side effects of antiviral therapy for chronic hepatitis C
Citation Override
Cleveland Clinic Journal of Medicine 2004 May;71(suppl 3):S17-S21
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media